Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 31, 2009

Novartis to Exploit Nuevolution Platform for Drug Discovery

  • Novartis enlisted the help of Danish drug discovery company Nuevolution to identify small molecule leads against specific drug targets. Nuevolution will use its fragment-based drug screening platform called Chemetics®. The company says this technology combines proven wet chemistry and molecular biology to allow the rapid synthesis and selection of ligands from potentially billions of drug-like compounds in a single test tube.  The companies will work together to carry out hit-to-lead optimization.

     



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »